A Holistic in Silico Approach to Develop Novel Inhibitors Targeting ErbB1 and ErbB2 Kinases

Tropical Journal of Pharmaceutical Research - Nigeria
doi 10.4314/tjpr.v15i2.3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

African Journals Online (AJOL)

Related search

An Integrated in Silico Approach to Design Specific Inhibitors Targeting Human Poly(A)-Specific Ribonuclease

PLoS ONE
Multidisciplinary
2012English

Combining Lapatinib (GW572016), a Small Molecule Inhibitor of ErbB1 and ErbB2 Tyrosine Kinases, With Therapeutic Anti-ErbB2 Antibodies Enhances Apoptosis of ErbB2-overexpressing Breast Cancer Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
2005English

A Holistic Approach to Develop IS Curricula: Focusing on Accreditation and IT Certification

Journal of Information Technology Education:Research
E-learningEducationComputer Science
2005English

LEDGF/p75 IN Interaction Inhibitors: In Silico Studies of an Old Target With Novel Approach

BMC Infectious Diseases
Infectious Diseases
2014English

A Novel Treatment Strategy Targeting Aurora Kinases in Acute Myelogenous Leukemia

Molecular Cancer Therapeutics
Cancer ResearchOncology
2007English

An in Silico Approach to Identify High Affinity Small Molecule Targeting M-Tor Inhibitors for the Clinical Treatment of Breast Cancer

Asian Pacific Journal of Cancer Prevention
2019English

In Silico Approach to Identification of a Novel Gene Responsive to Submergence Stress in Rice

African Journal of Biotechnology
2015English

Targeting MK2 Is a Novel Approach to Interfere in Multiple Myeloma

Frontiers in Oncology
Cancer ResearchOncology
2019English

A Holistic Approach to Combat Obesity

International Journal of Family & Community Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy